Recently published results from an evaluation of 1,065 chemical and drug substances using the devTOX quickPredict (devTOXqP) screening platform developed by Stemina Biomarker Discovery, Inc.

Pharmaceutical companies and governmental regulatory agencies are becoming increasingly aware of the need for improved statistical methods for developmental toxicity experiments. Although a number of ...

Charles River Laboratories International, Inc. (NYSE: CRL) and Toxys today announced a collaboration that offers Charles River’s clients access to ReproTracker®, a state-of-the-art human stem ...

(Nanowerk News) The environmental and health risks of graphene oxide (GO) attract considerable attention because of its wide-ranging applications in various field. GO, an extensively studied carbon ...

In 473 patients (283 in development and 190 in validation cohort), 46% developed grade 3-5 chemotherapy toxicities. Eight independent predictors were identified (each assigned weighted points): ...

In an analysis of more than 1,000 chemicals in fluids used in and created by hydraulic fracturing (fracking), Yale School of Public Health researchers found that many of the substances have been ...

New Rochelle, NY, October 30, 2014—Oligonucleotide-based therapeutics present unique challenges when it comes to testing their potential to cause reproductive and developmental harm. New consensus ...

Before the safety and efficacy of a new vaccine can be evaluated in a Phase I clinical trial with human subjects, it must first undergo non-clinical safety evaluation in animal models. Regulatory ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017" report to their offering. This ...